Grifols extends supply agreement with OraSure Technologies

Grifols has restated its 2005 agreement with OraSure Technologies for a five-year extension to supply recombinant antigens for OraSure's OraQuick HCV Rapid Antibody Test.

“Grifols announces that it has restated its 2005 agreement with OraSure Technologies”prnewswire.com

• 1 source
• prnewswire.comGrifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing FacilityGrifolsApr 24, 2017

Summarized from public sources; check the original articles before acting on it.